Scientists have documented the way a single gene in the bacterium that causes bubonic plague, Yersinia pestis, allowed it to survive hundreds of years by adjusting its virulence and the length of time it took to kill its victims, but these forms of plague ultimately died out.
A study by researchers at McMaster University and France’s Institut Pasteur, published in the journal Science, addresses some fundamental questions related to pandemics: how do they enter human populations, cause immense sickness, and evolve different levels of virulence to persist in populations?
The Black Death remains the single deadliest pandemic in recorded human history, killing an estimated 30–50% of the populations of Europe, Western Asia and Africa as it moved through those regions. Appearing in the 14th century, it re-emerged in waves over more than 500 years, persisting until 1840.
The Black Death was caused by the same bacteria which caused the Plague of Justinian, the first plague pandemic which had broken out in the mid-500s. The third plague pandemic began in China in 1855 and continues today. Its deadly effects are now more controlled by antibiotics but are still felt in regions like Madagascar and the Democratic Republic of Congo, where cases are regularly reported.
“This is one of the first research studies to directly examine changes in an ancient pathogen, one we still see today, in an attempt to understand what drives the virulence, persistence and/or eventual extinction of pandemics,” says Hendrik Poinar, co-senior author of the study, director of the McMaster Ancient DNA Center and holder of the Michael G. DeGroote Chair in Genetic Anthropology.
Strains of the Justinian plague became extinct after 300 years of ravaging European and Middle Eastern populations. Strains of the second pandemic emerged from infected rodent populations, causing the Black Death, before breaking into two major lineages. One of these two lineages is the ancestor of all present-day strains. The other re-emerged over centuries in Europe and ultimately went extinct by the early 19th century.
Using hundreds of samples from ancient and modern plague victims, the team screened for a gene known as pla, a high copy component of Y. pestis which helps it move through the immune system undetected to the lymph nodes before spreading to the rest of the body.
An extensive genetic analysis revealed that its copy number, or total number of pla genes found in the bacterium, had decreased in later outbreaks of the disease, which in turn decreased its mortality by 20% and increased the length of its infection, meaning the hosts lived longer before they died. These studies were performed in mice models of bubonic plague.
Conversely, when the pla gene was in its original, high copy number, the disease was much more virulent and killed each of its hosts and did so much quicker.

The scientists also identified a striking similarity between the trajectories of modern and ancient strains, which independently evolved similar reductions in pla in the later stages of the first and second pandemic, and so far, in three samples from the third pandemic, found in Vietnam today.
In both the Justinian and Black Death plagues, the evolutionary change occurred approximately 100 years after the first outbreaks. Scientists propose that when the gene copy number dropped and the infected rats lived longer, they could spread infection farther, ensuring the reproductive success of the pathogen.
“The reduction of pla may reflect the changing size and density of rodent and human populations,” explains Poinar. “It’s important to remember that the plague was an epidemic of rats, which were the drivers of epidemics and pandemics. Humans were accidental victims.”
Black rats in cities likely acted as “amplification hosts” due to their high numbers and proximity to humans. Because black rats are highly susceptible to Y. pestis, the pathogen needed rat populations to stay high enough to supply new hosts for Y. pestis to persist and allow the pandemic cycle to continue.
However, the pla-reduced strains eventually went extinct, likely reflecting another shift in the host-pathogen relationship within their environment.
When the researchers searched for signs of depletion in a large set of samples of the third pandemic preserved in a collection at the Institut Pasteur, they found three contemporary strains with pla depletion.
“Thanks to our international collaborators who monitor local epidemics of plague worldwide, we were able to find the unique bacterial samples used for this project, akin to finding three rare needles in a haystack,” says Javier Pizarro-Cerdá, co-senior author of the work, director of the Yersinia Research Unit and of the WHO Collaborating Center for Plague at the Institut Pasteur.
The institute houses one of the world’s richest collections of modern Y. pestis isolates, adds Guillem Mas Fiol, co-lead author of the study and postdoctoral researcher supervised by Pizarro-Cerdá.
“One of the most interesting aspects of our research was the possibility to explore a feature first observed in extinct plague strains, that could, for the first time, be experimentally tested in living contemporary bacterial strains,” he says.
“Although our research sheds light on an interesting pattern in the evolutionary history of plague, the majority of strains which continue to circulate today in Africa, South America and India are the more virulent ones, the ones that were previously responsible for massive mortality,” says Ravneet Sidhu, co-lead author of the study, and Ph.D. candidate at the McMaster Ancient DNA Center.
More information: Ravneet Kaur Sidhu et al, Attenuation of virulence in Yersinia pestis across three plague pandemics, Science (2025). DOI: 10.1126/science.adt3880. www.science.org/doi/10.1126/science.adt3880
Journal information: Science
News
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]















